Broadridge Reports Third Quarter and Nine Months Fiscal Year 2018 Results
May 08, 2018 11:01 am UTC| Business
Third Quarter Diluted EPS Growth of 43% and Adjusted EPS growth of 45% Total Revenues Rise 6% to $1.1 billion Recurring Revenues Increase 8% to $639 million Raising Fiscal Year 2018 EPS Guidance LAKE SUCCESS, N.Y.,...
OncoCyte to Report First Quarter 2018 Financial Results on May 15, 2018
May 08, 2018 11:01 am UTC| Business
ALAMEDA, Calif, May 08, 2018 -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, announced today that it will release its financial and...
RedHill Biopharma Reports First Quarter 2018 Financial Results
May 08, 2018 11:01 am UTC| Business
Key Highlights: Top-line results from Phase III study with RHB-104 for Crohn’s disease (MAP US study) expected in approximately 3 monthsTop-line results from confirmatory Phase III study with TALICIA® for H. pylori...
Ascendis Pharma A/S Announces Dosing of First Subjects in Phase 1 Trial of TransCon CNP
May 08, 2018 11:01 am UTC| Business
- TransCon CNP is Company’s Third Product Candidate in Clinic - COPENHAGEN, Denmark, May 08, 2018 -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to...
Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
May 08, 2018 11:01 am UTC| Business
- Topline data from second pivotal Phase 3 trial of lefamulin for CABP (LEAP 2) expected in Spring 2018 - - $90 million cash and investments as of March 31, 2018 expected to fund operations into the first quarter of 2020...
iATS Payments Names North America’s Most Innovative Nonprofits
May 08, 2018 11:01 am UTC| Business
Vancouver, May 08, 2018 -- iATS Payments (iATS), a leading provider of payment solutions for nonprofit organizations around the world, is giving back to North American nonprofits, and today announced the winners of the...
Antares Pharma Reports First Quarter 2018 Operating and Financial Results
May 08, 2018 11:01 am UTC| Business
EWING, N.J., May 08, 2018 -- Antares Pharma, Inc. (NASDAQ:ATRS) (the Company) today reported operating and financial results for the first quarter ended March 31, 2018. The Company reported revenue of $12.7 million and...